Paid Clinical Trials in Oregon

Oregon has 1,203 paid clinical trials enrolling now across cities including Portland, Eugene and Newberg. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,071 clinical trials

AMEND TS Early Feasibility Study

for Symptomatic Functional MR 3 or Greater

Sites in Portland +10 more locations

Sponsor: Valcare Medical Ltd.

Sex: All·Age: 21+

Code: NCT06951672·Recruiting·Listed Apr 2025

Apply to this trial

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

for Relapsed or Refractory T Cell Lymphoma

Sites in Portland +18 more locations

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All·Age: 18+

Code: NCT05079282·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

for Muscular Diseases

Sites in Portland +12 more locations

Sponsor: Arcellx, Inc.

Sex: All·Age: 18+

Code: NCT06626919·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

for Cystic Fibrosis

Sites in Portland +12 more locations

Sponsor: ReCode Therapeutics

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT06237335·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for Renal Cell Carcinoma

Sites in Portland +19 more locations

Sponsor: HiberCell, Inc.

Sex: All·Age: 18+

Code: NCT06234605·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

for Advanced or Metastatic Solid Tumors

Sites in Portland +9 more locations

Sponsor: Incendia Therapeutics

Sex: All·Age: 18+

Code: NCT05753722·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

for Chronic Myeloid Leukemia, Chronic Phase

Sites in Portland, Eugene +16 more locations

Sponsor: Terns, Inc.

Sex: All·Age: 18+

Code: NCT06163430·Phase 1, Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

for Cachexia

Sites in Portland +11 more locations

Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05865535·Phase 1·Recruiting·Listed May 2023

Apply to this trial

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

Sites in Portland +21 more locations

Sponsor: Servier Bio-Innovation LLC

Sex: All·Age: 18+

Code: NCT06127407·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

for Epilepsy, Temporal Lobe

Sites in Portland +15 more locations

Sponsor: Neurona Therapeutics

Sex: All·Age: 18 - 75

Code: NCT06422923·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for Small Cell Lung Cancer Extensive Stage

Drug: Atezolizumab

Sites in Portland, Eugene +14 more locations

Sponsor: Genprex, Inc.

Sex: All·Age: 18+

Code: NCT05703971·Phase 1, Phase 2·Recruiting·Listed Jan 2023

Apply to this trial

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Portland +10 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06459973·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Sites in Portland +15 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06747351·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

for Viral Pneumonia

Sites in Portland +21 more locations

Sponsor: Synairgen Research Ltd.

Sex: All·Age: 18+

Code: NCT06999603·Phase 2·Recruiting·Listed May 2025

Apply to this trial

TTVR Early Feasibility Study

for Tricuspid Regurgitation

Sites in Portland +18 more locations

Sponsor: Medtronic Cardiovascular

Sex: All·Age: 18+

Code: NCT04433065·Recruiting·Listed Jun 2020

Apply to this trial

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for Stargardt Disease

Sites in Portland +9 more locations

Sponsor: Ascidian Therapeutics, Inc

Sex: All·Age: 12+

Code: NCT06467344·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

for Coronary Artery Disease

Sites in Portland +23 more locations

Sponsor: Concept Medical Inc.

Sex: All·Age: 18 - 80

Code: NCT06271590·Recruiting·Listed Feb 2024

Apply to this trial

TVMR With the INNOVALVE System Trial - Early Feasibility Study

for Mitral Valve Regurgitation (Degenerative or Functional)

Sites in Portland +18 more locations

Sponsor: Edwards Lifesciences

Sex: All·Age: 18+

Code: NCT04919980·Recruiting·Listed Jun 2021

Apply to this trial

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

for Acute Ischemic Stroke From Large Vessel Occlusion

Sites in Portland +10 more locations

Sponsor: Anaconda Biomed S.L.

Sex: All·Age: 22 - 85

Code: NCT06370182·Recruiting·Listed Apr 2024

Apply to this trial

Serranator POINT FORCE Registry

for Peripheral Artery Disease (PAD)

Sites in Portland +17 more locations

Sponsor: Cagent Vascular LLC

Sex: All·Age: 18+

Code: NCT06687590·Recruiting·Listed Nov 2024

Apply to this trial

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

for Advanced Solid Tumor

Sites in Portland +9 more locations

Sponsor: Circle Pharma

Sex: All·Age: 12+

Code: NCT06577987·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

Total Shoulder Arthroplasty Multi-Center Registry

for Shoulder Arthroplasty

Sites in Medford +14 more locations

Sponsor: Arthrex, Inc.

Sex: All·Age: 18 - 100

Code: NCT03511586·Recruiting·Listed Apr 2018

Apply to this trial

AltaValve Pivotal Trial

for Mitral Regurgitation

Sites in Portland +19 more locations

Sponsor: 4C Medical Technologies, Inc.

Sex: All·Age: 18+

Code: NCT06465745·Recruiting·Listed Jun 2024

Apply to this trial

Study of AVZO-021 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Portland +10 more locations

Sponsor: Avenzo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05867251·Phase 1, Phase 2·Recruiting·Listed May 2023

Apply to this trial

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for Solid Tumor, Adult

Sites in Portland +12 more locations

Sponsor: GV20 Therapeutics

Sex: All·Age: 18+

Code: NCT05669430·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

MB-105 in Patients With CD5 Positive T-cell Lymphoma

for Lymphoma, T-Cell

Sites in Portland +11 more locations

Sponsor: March Biosciences Inc

Sex: All·Age: 18+

Code: NCT06534060·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

for Stargardt

Sites in Portland +13 more locations

Sponsor: Splice Bio

Sex: All·Age: 12 - 65

Code: NCT06435000·Recruiting·Listed May 2024

Apply to this trial

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

for Polycythemia Vera

Drug: Givinostat

Sites in Eugene +13 more locations

Sponsor: Italfarmaco

Sex: All·Age: 18+

Code: NCT06093672·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

ConsideRAte Study - Splenic Stimulation for RA

for Rheumatoid Arthritis

Sites in Portland +9 more locations

Sponsor: Galvani Bioelectronics

Sex: All·Age: 22 - 75

Code: NCT05003310·Recruiting·Listed Aug 2021

Apply to this trial

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

for Migraine Disorders

Sites in Portland, Springfield +4 more locations

Sponsor: Upsher-Smith Laboratories

Sex: All·Age: 6 - 11

Code: NCT04748601·Phase 4·Recruiting·Listed Feb 2021

Apply to this trial

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for Brain Cancer

Sites in Portland +15 more locations

Sponsor: Adela, Inc

Sex: All·Age: 40+·Accepts healthy volunteers

Code: NCT05366881·Recruiting·Listed May 2022

Apply to this trial

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for AML With Gene Mutations

Sites in Portland +11 more locations

Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All·Age: 18+

Code: NCT06366789·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

for Higher-risk Myelodysplastic Syndromes

Sites in Eugene +13 more locations

Sponsor: Akeso

Sex: All·Age: 18+

Code: NCT06196203·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for Endometrial Cancer

Sites in Portland, Eugene +17 more locations

Sponsor: Kartos Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT05797831·Phase 2, Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for TNBC - Triple-Negative Breast Cancer

Sites in Salem +13 more locations

Sponsor: Personalis Inc.

Sex: Female·Age: 18+

Code: NCT06230185·Recruiting·Listed Jan 2024

Apply to this trial

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

for Acute Myeloid Leukemia, in Relapse

Drug: Iadademstat

Sites in Portland +12 more locations

Sponsor: Oryzon Genomics S.A.

Sex: All·Age: 18+

Code: NCT05546580·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for HR+ HER2- Breast Cancer

Sites in Springfield +6 more locations

Sponsor: Faeth Therapeutics

Sex: All·Age: 18+

Code: NCT07558733·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for Colorectal Cancer

Drug: Bevacizumab

Sites in Portland +3 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07525206·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for Cardiovascular

Sites in Portland +8 more locations

Sponsor: CRISPR Therapeutics AG

Sex: All·Age: 18 - 75

Code: NCT07491172·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

for EGFR Mutation Positive Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Eugene +5 more locations

Sponsor: Nuvectis Pharma, Inc.

Sex: All·Age: 18+

Code: NCT07315113·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial